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response to viruses. These may increase the susceptibility to disseminated neonatal HSV
disease. 
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Background:
Limited data exist on the role of human parechoviruses (HPeV) and enteroviruses (EV) as
causes of late-onset sepsis (LOS) in the NICU. 
Objective:
To determine the frequency of detection of parechoviruses and enteroviruses among infants >72
hr of age who were evaluated for LOS in 2 academic NICUs (Parkland Memorial Hospital [PMH],
Dallas -shared bays; Women & Infants Hospital [W&I], RI -single patient rooms) 
Design/Methods:
Prospective cohort study of inborn infants hospitalized in the NICU at PMH and WIH from 1/2012
to 1/2013 and were enrolled in the Viral Respiratory Infections in the Neonatal Intensive Care
Unit (VIRIoN-I; J Pediatr 2014:165:690). Eligible subjects were infants of all gestational ages
(GA) and birth weights (BW) who were >72 hrs of age, remained in the NICU since birth, and
underwent evaluation with initiation of antibiotic therapy for suspected LOS. Nasopharyngeal
specimens were obtained within 72 hrs of the sepsis evaluation using flexible flocked nylon
swabs that were placed in universal transport medium and frozen at -80°C until tested for
parechovirus and enterovirus RNA by polymerase chain reaction (PCR) assay (Virology
Laboratory, Nationwide Children’s Hospital, Columbus, OH). Demographic, clinical, laboratory,
and radiographic data were obtained. 
Results:
Of the 100 infants enrolled in the VIRIoN-I study, nasopharyngeal specimens were available from
65 (59, PMH; 6, WIH) for parechovirus and enterovirus PCR testing. These 65 infants (38, male;
27, female; 49, Hispanic; 6, white; 9, Black; 1, unknown) had a mean ±SD gestational age of 30
± 5 wks and birth weight of 1619 ± 929 g, and received empirical antibiotics for possible LOS.
Infants had a total of 94 sepsis evaluations (65, 1 evaluation; 16, 2; 8, 3; 4, 4) at a mean age of
20 days. Reasons for the sepsis evaluations included fever (9), hypothermia (65), apnea (50),
Detection of Parechovirus (P) and Enterovirus (E) Among Infants
Evaluated for Late-Onset Sepsis in the Neonatal Intensive Care Unit
(NICU): The VIRIoN-P-E Study (Board 533)
Reginald Woods, Nationwide Children's Hospital - The Ohio State University; Huanyu Wang,
Nationwide Children's Hospital; Andrea Ronchi, NICU, Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico, University of Milan; Ian Michelow, Brown University; Amy
Leber, Nationwide Children's Hospital; Carlo Pietrasanta, NICU, Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, University of Milan; Lorenza Pugni, NICU,
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan; Pablo
Sanchez, Nationwide Children's Hospital - The Ohio State University

18/09/2019 PAS 2019
https://www.xcdsystem.com/pas/program/2019/index.cfm?pgid=156&print=1&printmode=1 5/8
feeding intolerance (51), seizure (1), irritabilitiy (5), emesis (20), diarrhea (1), bloody stool (5),
rhinorrhea/congestion/cough (6), and lethargy (9). Four infants died. None of the infants had
parechovirus or enterovirus detected in nasopharygeal specimens either at the first or
subsequent sepsis evaluations. 
Conclusion(s):
The burden of disease due to parechovirus and enteroviruses among inborn infants who remain
in the NICU since birth appears to be low in those evaluated for LOS. Larger, prospective studies
are needed to fully determine their contribution to “culture-negative” sepsis in the NICU. 
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Background:
Hepatitis C virus infection is a major public health problem among pregnant women in Ohio.
Timely and targeted testing of at-risk women is recommended for optimal identification of
exposed infants. 
Objective:
To determine the prevalence of hepatitis C virus infection among mothers of newborns with NAS
and identify gaps in optimal testing of mothers during pregnancy and delivery 
Design/Methods:
Newborns with Neonatal Abstinence Syndrome (NAS) admitted to the neonatal intensive care
units (NICUs) at The Ohio State University Wexner Medical Center and Nationwide Children’s
Hospital (NCH) from 9/16 to 9/18 were identified by review of the NCH NAS database. Pertinent
demographic and clinical data were obtained from both mother and infant that included dates of
maternal hepatitis C virus testing. 
Results:
349 infants were admitted to the NICU due to NAS, and preliminary data are available for 60
infants born to 59 mothers. Of the 59 mothers, 32 (54%) had hepatitis C virus infection
documented before or during pregnancy. Seven (12%) of the 59 mothers were never tested
either before or at delivery. Of the remaining 20 mothers, 9 (45%) were tested at delivery while 11
(55%) had a negative hepatitis C antibody test early in pregnancy but not retested at delivery
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